Your browser doesn't support javascript.
loading
Recommendations from the AML molecular MRD expert advisory board.
Scott, Stuart; Devonshire, Alison; Dillon, Richard; Thiede, Christian; Cross, Nicholas C P; White, Helen E; Lo Cascio, Leandro; Mokretar, Katya; Potter, Nicola; Hourigan, Christopher S; Radich, Jerald; Corner, Adam; Laloux, Véronique; Halliday, Gemma; Dilks, Daniel; Morrison, Tom; Gilmour, Katelyn; Cartwright, Ashley; Whitby, Liam.
Afiliación
  • Scott S; UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. stuart.scott@ukneqasli.co.uk.
  • Devonshire A; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. stuart.scott@ukneqasli.co.uk.
  • Dillon R; Molecular and Cell Biology, National Measurement Laboratory, LGC, Teddington, UK.
  • Thiede C; Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas NHS Foundation Trust, London, UK.
  • Cross NCP; Department of Medical and Molecular Genetics, King's College, London, UK.
  • White HE; University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
  • Lo Cascio L; AgenDix, Applied Molecular Diagnostics, GmbH, Dresden, Germany.
  • Mokretar K; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Potter N; Wessex Genomics Laboratory Service, Salisbury District Hospital, Salisbury, UK.
  • Hourigan CS; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Radich J; Wessex Genomics Laboratory Service, Salisbury District Hospital, Salisbury, UK.
  • Corner A; Diagnostics R&D, Medicines and Healthcare Products Regulatory Agency (MHRA), Potters Bar, UK.
  • Laloux V; Cancer Genetics, Guy's Hospital, Synnovis, London, UK.
  • Halliday G; Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas NHS Foundation Trust, London, UK.
  • Dilks D; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
  • Morrison T; Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Gilmour K; Digital Biology Group, Bio-Rad Laboratories, Pleasanton, CA, USA.
  • Cartwright A; Translational Science and Precision Diagnostics, QIAGEN, Courtaboeuf, France.
  • Whitby L; Horizon Discovery, Diagnostic Reference Standards, Cambridge, UK.
Leukemia ; 38(7): 1638-1641, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38783160

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Comités Consultivos Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Comités Consultivos Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article